ACHE and Alzheimer disease: Pentacylcic pyranotacrines bearing a fused naphthalene, quinoline, or naphthoquinone moiety (Scheme 3A) have shown diverse anti-AD activity, including AChE inhibition, BACE1 inhibition, ROS scavenging, and metal chelation [71,72,73,74].